Druggio Logo

Druggio

Chugai (Roche)

Chugai Pharmaceutical Co., Ltd. is a pharmaceutical company based in Japan and is a member of the Roche Group. The company was founded in 1925 and has a focus on the research and development of innovative pharmaceutical products, particularly in the areas of oncology, immunology, and other specialized therapeutic areas. Chugai has developed drugs for the treatment of various diseases such as cancer, rheumatoid arthritis, and other autoimmune disorders. Their commitment to scientific innovation and collaboration with Roche positions them as a leading player in the global pharmaceutical industry.

Chugai (Roche)'s Drugs

Ronapreve

Approval date

2021/7/19

Treats

Evrysdi

Approval date

2021/6/23

Enspryng

Approval date

2020/6/29

Rozlytrek

Approval date

2019/6/18

Gazyva

Approval date

2018/7/2

Hemlibra

Approval date

2018/3/23

Treats

Zelboraf

Approval date

2014/12/26

Treats

Kadcyla

Approval date

2013/9/20

Bonviva

Approval date

2013/6/28

Treats

Perjeta

Approval date

2013/6/28

Pulmozyme

Approval date

2012/3/30

Mircera

Approval date

2011/4/22

Treats

Edirol

Approval date

2011/1/21

Treats

Tarceva

Approval date

2007/10/19

Renagel, Phosblock

Approval date

2003/1/31

Herceptin

Approval date

2001/4/4

Tamiflu

Approval date

2000/12/12

Treats